Emmessar Biotech & Nutrition Ltd

₹ 34.8 2.17%

17 Apr - close price

About

Incorporated in 1992, Emmessar Biotech & Nutrition Ltd is in the business of Healthcare, Fine Chemicals and Renting of Immovable property^[1]

Key Points

Business Overview:^[1]
EBNL is a global healthcare company that manufactures and markets healthcare & nutritional products. It fuses various concepts & principles (both ancient & modern) from Biophysics, Biochemistry, Biotechnology and the Indian system of medicine AYUSH (Ayurveda + Yoga + Unani + Siddha + Homeopathy) to create products. This integration resulted in technology called VedaCeuticals which forms the foundation of all products of EBNL

Website BSE

Market Cap ₹ 17.4 Cr.
Current Price ₹ 34.8
High / Low ₹ 64.0 / 27.2
Stock P/E 22.9
Book Value ₹ 15.6
Dividend Yield 0.00 %
ROCE 11.4 %
ROE 10.6 %
Face Value ₹ 10.0

Add ratio to table

Edit ratios

Pros

Company has reduced debt.
Company is almost debt free.

Cons

Though the company is reporting repeated profits, it is not paying out dividend
The company has delivered a poor sales growth of -2.33% over past five years.
Company has a low return on equity of 8.92% over last 3 years.
Working capital days have increased from 81.8 days to 163 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Chemicals Industry: Chemicals

Edit Columns

Loading peers table ...

Detailed Comparison with:

Quarterly Results

Figures in Rs. Crores

	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024
	0.16	0.15	0.21	0.07	0.43	0.32	0.07	0.08	0.33	0.08	0.08	0.34	0.10
	0.38	0.33	0.36	0.27	0.60	0.48	0.35	0.30	0.54	0.47	0.36	0.42	0.38
Operating Profit	-0.22	-0.18	-0.15	-0.20	-0.17	-0.16	-0.28	-0.22	-0.21	-0.39	-0.28	-0.08	-0.28
OPM %	-137.50%	-120.00%	-71.43%	-285.71%	-39.53%	-50.00%	-400.00%	-275.00%	-63.64%	-487.50%	-350.00%	-23.53%	-280.00%
	0.41	0.71	0.44	0.43	0.44	0.42	0.46	0.53	0.53	0.48	0.46	0.51	0.43
Interest	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Depreciation	0.02	0.04	0.02	0.02	0.02	0.02	0.02	0.02	0.02	0.02	0.02	0.02	0.02
Profit before tax	0.17	0.49	0.27	0.21	0.25	0.24	0.16	0.29	0.30	0.07	0.16	0.41	0.13
Tax %	0.00%	91.84%	25.93%	33.33%	108.00%	20.83%	68.75%	31.03%	56.67%	-428.57%	43.75%	31.71%	84.62%
	0.17	0.03	0.20	0.13	-0.02	0.20	0.05	0.20	0.13	0.37	0.09	0.28	0.02
EPS in Rs	0.34	0.06	0.40	0.26	-0.04	0.40	0.10	0.40	0.26	0.74	0.18	0.56	0.04
Raw PDF

Upcoming result date: 24 April 2025

Profit & Loss

Figures in Rs. Crores

	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM
	0.58	1.37	2.19	1.98	2.61	1.27	0.63	3.40	6.99	0.36	1.02	0.56	0.60
	0.77	1.43	2.34	2.66	2.38	1.67	1.27	3.81	6.15	1.26	1.71	1.64	1.63
Operating Profit	-0.19	-0.06	-0.15	-0.68	0.23	-0.40	-0.64	-0.41	0.84	-0.90	-0.69	-1.08	-1.03
OPM %	-32.76%	-4.38%	-6.85%	-34.34%	8.81%	-31.50%	-101.59%	-12.06%	12.02%	-250.00%	-67.65%	-192.86%	-171.67%
	0.08	0.09	0.06	0.03	0.98	1.25	1.01	1.21	1.47	1.92	1.75	1.99	1.88
Interest	0.00	0.00	0.00	0.00	0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Depreciation	0.07	0.20	0.07	0.03	0.01	0.05	0.08	0.06	0.06	0.09	0.09	0.10	0.08
Profit before tax	-0.18	-0.17	-0.16	-0.68	1.19	0.80	0.29	0.74	2.25	0.93	0.97	0.81	0.77
Tax %	0.00%	82.35%	-25.00%	-30.88%	0.00%	-15.00%	-82.76%	-2.70%	36.00%	48.39%	47.42%	7.41%
	-0.18	-0.31	-0.12	-0.47	1.19	0.91	0.53	0.75	1.45	0.48	0.50	0.75	0.76
EPS in Rs	-0.36	-0.62	-0.24	-0.94	2.38	1.82	1.06	1.50	2.90	0.96	1.00	1.50	1.52
Dividend Payout %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Compounded Sales Growth
10 Years:	-9%
5 Years:	-2%
3 Years:	-57%
TTM:	-25%

Compounded Profit Growth
10 Years:	16%
5 Years:	0%
3 Years:	-20%
TTM:	31%

Stock Price CAGR
10 Years:	9%
5 Years:	25%
3 Years:	2%
1 Year:	-10%

Return on Equity
10 Years:	17%
5 Years:	15%
3 Years:	9%
Last Year:	11%

Balance Sheet

Figures in Rs. Crores

	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Sep 2024
Equity Capital	5.00	5.00	5.00	5.00	5.00	5.00	5.00	5.00	5.00	5.00	5.00	5.00	5.00
Reserves	-3.04	-3.42	-3.62	-4.09	-2.91	-2.01	-1.49	-0.73	0.70	1.17	1.67	2.41	2.77
	0.00	0.00	0.00	0.00	0.00	0.00	0.07	0.00	0.00	0.00	0.08	0.11	0.00
	2.97	0.65	1.03	1.36	1.13	0.92	1.59	1.86	2.11	1.04	1.19	1.23	1.52
Total Liabilities	4.93	2.23	2.41	2.27	3.22	3.91	5.17	6.13	7.81	7.21	7.94	8.75	9.29
	1.84	1.58	1.42	0.73	0.72	2.25	1.99	1.91	1.86	2.07	2.00	1.91	1.86
CWIP	0.00	0.00	0.00	0.00	0.80	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01
	3.08	0.64	0.98	1.53	1.69	1.65	3.17	4.21	5.94	5.13	5.93	6.83	7.42
Total Assets	4.93	2.23	2.41	2.27	3.22	3.91	5.17	6.13	7.81	7.21	7.94	8.75	9.29

Cash Flows

Figures in Rs. Crores

	Mar 2013	Mar 2015	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
	-0.02	-0.01	0.75	0.74	0.39	1.03	0.47	2.27	0.38	0.64
	-0.01	0.00	-0.74	-0.69	-0.37	-1.06	0.01	-2.61	-0.55	-0.64
	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Cash Flow	-0.03	-0.01	0.01	0.05	0.01	-0.03	0.48	-0.34	-0.17	0.00

Ratios

Figures in Rs. Crores

	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Debtor Days	1,686.55	45.29	6.67	66.36	5.59	8.62	23.17	3.22	141.51	10.14	3.58	13.04
Inventory Days	529.25	267.67	335.80	136.88	121.67	52.14	2,049.62	272.56	7.24	196.54	127.75	164.25
Days Payable	5,146.50	121.67	150.87	76.04	76.04	5.79	1,628.46	189.61	51.70	56.15	0.00	18.25
Cash Conversion Cycle	-2,930.70	191.29	191.60	127.20	51.22	54.97	444.33	86.18	97.05	150.52	131.33	159.04
Working Capital Days	37.76	29.31	38.33	22.12	85.31	175.31	498.25	30.06	79.37	-60.83	143.14	162.95
ROCE %	-8.78%	-9.60%	-10.81%	-39.30%	80.00%	31.50%	17.66%	25.48%	45.14%	15.67%	15.02%	11.35%

Shareholding Pattern

Numbers in percentages

	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025
	58.20%	58.20%	58.53%	59.08%	59.33%	59.53%	59.53%	59.53%	59.53%	59.53%	59.53%	59.53%
	0.19%	0.19%	0.19%	0.19%	0.19%	0.19%	0.19%	0.19%	0.19%	0.19%	0.19%	0.19%
	41.61%	41.61%	41.27%	40.73%	40.46%	40.27%	40.28%	40.26%	40.27%	40.27%	40.28%	40.27%
No. of Shareholders	6,970	6,975	7,024	6,933	6,874	6,822	6,844	7,146	6,900	6,936	7,186	7,180

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
	58.16%	58.26%	58.27%	58.46%	58.50%	58.50%	59.08%	59.53%	59.53%
	0.20%	0.20%	0.20%	0.20%	0.20%	0.20%	0.19%	0.19%	0.19%
	41.64%	41.54%	41.53%	41.35%	41.31%	41.31%	40.73%	40.26%	40.27%
No. of Shareholders	6,036	6,069	6,096	6,063	6,168	6,999	6,933	7,146	7,180

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

All

Emmessar Biotech & Nutrition Ltd

Emmessar Biotech & Nutrition Ltd

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Cash Flows

Ratios

Shareholding Pattern

Documents

Announcements

Annual reports